Re: 6%

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

fuzzyjr

Rank: Vice President [?]

Points: 5268 [?]

Votes: 36 Score: 3.1 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: 6%

in response to

Re: 6%

fuzzyjr

posted on Dec 15, 2022 11:28AM

+ if we were given some cash for zen-3694 + shown the exit door would we the sharholder still get a 6% royalty off of zen-3694 for years to come?

1 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply